Sanjivani Paranteral Limited (BOM:531569)
145.75
-4.20 (-2.80%)
At close: May 27, 2026
Sanjivani Paranteral Revenue
In the fiscal year ending March 31, 2026, Sanjivani Paranteral had annual revenue of 686.66M INR, down -2.04%. Sanjivani Paranteral had revenue of 132.13M in the quarter ending March 31, 2026, a decrease of -27.33%.
Revenue
686.66M
Revenue Growth
-2.04%
P/S Ratio
2.68
Revenue / Employee
17.17M
Employees
40
Market Cap
1.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 686.66M | -14.33M | -2.04% |
| Mar 31, 2025 | 700.99M | 156.88M | 28.83% |
| Mar 31, 2024 | 544.11M | 189.19M | 53.31% |
| Mar 31, 2023 | 354.92M | 48.79M | 15.94% |
| Mar 31, 2022 | 306.13M | 55.13M | 21.96% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.40B |
| Bal Pharma | 3.09B |
| Parnax Lab | 2.28B |
| Ambalal Sarabhai Enterprises | 2.17B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.29B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |